We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
1751
DELISTED
Brookline Bancorp
BRKL
| $186K | ﹤0.01% |
18,419
+4,942
| +37% | +$48.5K |
|
1752
New Mountain Finance
NMFC
$646M
| $186K | ﹤0.01% |
15,497
+602
| +4% | +$7.35K |
|
1753
Pacira BioSciences
PCRX
$1.02B
| $185K | ﹤0.01% |
12,293
+2,389
| +24% | +$40.8K |
|
1754
Lifestance Health
LFST
$4.16B
| $184K | ﹤0.01% |
26,357
+12,141
| +85% | +$73K |
|
1755
Applied Digital
APLD
$7.77B
| $183K | ﹤0.01% |
22,220
+10,524
| +90% | +$55.8K |
|
1756
American Express Global Business Travel
GBTG
$4.91B
| $182K | ﹤0.01% |
+23,715
| New | +$164K |
|
1757
Green Plains
GPRE
$1.19B
| $180K | ﹤0.01% |
+13,311
| New | +$195K |
|
|
DX
1758
Dynex Capital
DX
$2.99B
| $179K | ﹤0.01% |
+14,058
| New | +$174K |
|
1759
Century Aluminum
CENX
$4.57B
| $178K | ﹤0.01% |
+10,997
| New | +$167K |
|
1760
FTAI Infrastructure
FIP
$500M
| $178K | ﹤0.01% |
19,032
+5,774
| +44% | +$53.6K |
|
1761
Snap
SNAP
$7.32B
| $178K | ﹤0.01% |
16,635
+480
| +3% | +$5.47K |
|
1762
National Vision
EYE
$1.6B
| $177K | ﹤0.01% |
16,259
+4,282
| +36% | +$50K |
|
|
BASE
1763
DELISTED
Couchbase
BASE
| $175K | ﹤0.01% |
+10,849
| New | +$188K |
|
1764
Vuzix
VUZI
$190M
| $175K | ﹤0.01% |
149,348
-195
| -0.1% | -$213 |
|
1765
Krispy Kreme
DNUT
$543M
| $174K | ﹤0.01% |
16,167
+4,434
| +38% | +$48.2K |
|
1766
Arcus Biosciences
RCUS
$3.57B
| $173K | ﹤0.01% |
+11,341
| New | +$179K |
|
1767
NuScale Power
SMR
$2.8B
| $173K | ﹤0.01% |
+14,965
| New | +$153K |
|
1768
BrightView Holdings
BV
$1.31B
| $173K | ﹤0.01% |
+10,990
| New | +$159K |
|
|
DHC
1769
Diversified Healthcare Trust
DHC
$2.26B
| $173K | ﹤0.01% |
41,274
+9,253
| +29% | +$31.2K |
|
|
PGRE
1770
DELISTED
Paramount Group
PGRE
| $172K | ﹤0.01% |
34,865
+10,069
| +41% | +$49.9K |
|
1771
Healthcare Services Group
HCSG
$1.56B
| $171K | ﹤0.01% |
15,349
+3,905
| +34% | +$42.9K |
|
1772
Enviri
NVRI
$621M
| $171K | ﹤0.01% |
16,551
+4,377
| +36% | +$46.1K |
|
1773
Globalstar
GSAT
$10.2B
| $171K | ﹤0.01% |
9,190
+2,720
| +42% | +$50.3K |
|
|
ETWO
1774
DELISTED
E2open Parent Holdings
ETWO
| $171K | ﹤0.01% |
38,667
+15,625
| +68% | +$68.3K |
|
1775
Embecta
EMBC
$195M
| $170K | ﹤0.01% |
+12,088
| New | +$176K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.